Search results
Structure Therapeutics Stock Soars on Obesity Pill Data
The Wall Street Journal· 56 minutes agoStructure’s once-daily drug, code-named GSBR-1290, helped people lose an average of more than 6% of...
Eli Lilly adds ALS drug prospect with QurAlis deal
BioPharma Dive via Yahoo Finance· 11 hours agoThe alliance hands Lilly an RNA-based therapy in preclinical testing for ALS and frontotemporal dementia, and includes a research collaboration to...
Is Eli Lilly And Co (NYSE:LLY) the Best Weight Loss Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 3 days agoWe recently published a list of Jim Cramer’s Top 10 Stock Picks for June. Since Eli Lilly And Co...
Eli McKamey, 15, scores exceptional status to play with the B.C. Hockey League
CBC via Yahoo News· 2 days agoEli McKamey, 15, made history after the British Columbia Hockey League (BCHL) granted him...
Playbook: The Trump verdict lands on the Hill
Politico· 6 hours agoWith help from Eli Okun, Garrett Ross and Bethany Irvine WAPO SHOCKER — SALLY BUZBEE is out as the Washington Post’s executive editor after a three-year run, to be immediately ...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
Motley Fool via Yahoo Finance· 2 days agoEli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are the two most valuable healthcare companies in...
Sandites pitcher Eli Buxton wins in OBCA All-State Game
Tulsa World· 12 hours agoAfter leading the Sandites to a Class 6A state championship game appearance in May, Charles Page...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors | The Motley Fool
The Motley Fool· 2 days agoEli Lilly (LLY 0.65%) and Novo Nordisk (NVO 1.87%) are the two most valuable healthcare companies in...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 4 days agoEli Lilly stock rocketed and broke out earlier this month after unveiling promising results for its...
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
Motley Fool via Yahoo Finance· 2 hours agoViking Therapeutics Viking Therapeutics (NASDAQ: VKTX) is disruptive because it could have a shot at...